EPHA2 and neoplasm: Based on these data and our observed elevation of EphA2 in bone metastatic lesions relative to lesions from other metastatic sites, we hypothesized that EphA2 might play a key role in aberrant bone remodeling caused by increased expression in tumors where it mediates bone cell–tumor cell interactions.